Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014

ABSTRACT The emergence of Neisseria gonorrhoeae strains with decreased susceptibility to cephalosporins and azithromycin (AZM) resistance (AZMr) represents a public health threat of untreatable gonorrhea infections. Genomic epidemiology through whole-genome sequencing was used to describe the emergence, dissemination, and spread of AZMr strains. The genomes of 213 AZMr and 23 AZM-susceptible N. gonorrhoeae isolates collected in Canada from 1989 to 2014 were sequenced. Core single nucleotide polymorphism (SNP) phylogenomic analysis resolved 246 isolates into 13 lineages. High-level AZMr (MICs ≥ 256 μg/ml) was found in 5 phylogenetically diverse isolates, all of which possessed the A2059G mutation (Escherichia coli numbering) in all four 23S rRNA alleles. One isolate with high-level AZMr collected in 2009 concurrently had decreased susceptibility to ceftriaxone (MIC = 0.125 μg/ml). An increase in the number of 23S rRNA alleles with the C2611T mutations (E. coli numbering) conferred low to moderate levels of AZMr (MICs = 2 to 4 and 8 to 32 μg/ml, respectively). Low-level AZMr was also associated with mtrR promoter mutations, including the −35A deletion and the presence of Neisseria meningitidis-like sequences. Geographic and temporal phylogenetic clustering indicates that emergent AZMr strains arise independently and can then rapidly expand clonally in a region through local sexual networks.

[1]  W. Shafer,et al.  Decreased Azithromycin Susceptibility ofNeisseria gonorrhoeae Due to mtrRMutations , 1999, Antimicrobial Agents and Chemotherapy.

[2]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[3]  L. Ng,et al.  Mutation in 23S rRNA Associated with Macrolide Resistance in Neisseria gonorrhoeae , 2002, Antimicrobial Agents and Chemotherapy.

[4]  W. Whittington,et al.  Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. , 2003, The Journal of antimicrobial chemotherapy.

[5]  Douglas M. Warner,et al.  Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC‐MtrD‐MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness , 2008, Molecular microbiology.

[6]  H. Palmer,et al.  Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. , 2008, The Journal of antimicrobial chemotherapy.

[7]  R. Howe,et al.  Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. , 2009, The Journal of antimicrobial chemotherapy.

[8]  P. Stefanelli,et al.  Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. , 2009, The Journal of antimicrobial chemotherapy.

[9]  J. Vázquez,et al.  Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. , 2009, Sexually transmitted diseases.

[10]  M. Unemo,et al.  Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. , 2009, The Journal of antimicrobial chemotherapy.

[11]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[12]  J. Tapsall Australian gonococcal surveillance. , 2009 .

[13]  Pushkala Jayaraman,et al.  A computational genomics pipeline for prokaryotic sequencing projects , 2010, Bioinform..

[14]  M. Unemo,et al.  Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  S. Chisholm,et al.  High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes , 2010, Antimicrobial Agents and Chemotherapy.

[16]  O. Gascuel,et al.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.

[17]  M. Unemo,et al.  Resistance to Azithromycin of Neisseria gonorrhoeae Isolates From 2 Cities in China , 2011, Sexually transmitted diseases.

[18]  M. Unemo,et al.  High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure , 2011, Antimicrobial Agents and Chemotherapy.

[19]  M. Unemo,et al.  Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone , 2011, Antimicrobial Agents and Chemotherapy.

[20]  Alexandre P. Francisco,et al.  PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods , 2012, BMC Bioinformatics.

[21]  A Stary,et al.  First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  K. Sankar,et al.  Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[23]  Steven Salzberg,et al.  BIOINFORMATICS ORIGINAL PAPER , 2004 .

[24]  Sergey I. Nikolenko,et al.  SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..

[25]  M. Gilmour,et al.  Emergence and Characterization of Neisseria gonorrhoeae Isolates With Decreased Susceptibilities to Ceftriaxone and Cefixime in Canada: 2001–2010 , 2012, Sexually transmitted diseases.

[26]  G. Horsman,et al.  Longitudinal Analysis of the Evolution and Dissemination of Neisseria gonorrhoeae Strains (Saskatchewan, Canada, 2005 to 2008) Reveals Three Major Circulating Strains and Convergent Evolution of Ciprofloxacin and Azithromycin Resistance , 2012, Journal of Clinical Microbiology.

[27]  K. Holmes,et al.  Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  S. Drews,et al.  Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada. , 2013, Sexually transmitted diseases.

[29]  I. Martin,et al.  Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. , 2013, JAMA.

[30]  Samantha Lycett,et al.  Automated analysis of phylogenetic clusters , 2013, BMC Bioinformatics.

[31]  M. Unemo,et al.  First Three Neisseria gonorrhoeae Isolates with High-Level Resistance to Azithromycin in Sweden: a Threat to Currently Available Dual-Antimicrobial Regimens for Treatment of Gonorrhea? , 2013, Antimicrobial Agents and Chemotherapy.

[32]  M. Unemo,et al.  Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.

[33]  I. Martin,et al.  Azithromycin Resistance Is Coevolving with Reduced Susceptibility to Cephalosporins in Neisseria gonorrhoeae in Ontario, Canada , 2014, Antimicrobial Agents and Chemotherapy.

[34]  Torsten Seemann,et al.  Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..

[35]  C. del Rio,et al.  Analysis of Neisseria gonorrhoeae Azithromycin Susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013 , 2014, Antimicrobial Agents and Chemotherapy.

[36]  J. Bates,et al.  A Neisseria gonorrhoeae strain with a meningococcal mtrR sequence. , 2014, Journal of medical microbiology.

[37]  Julian Parkhill,et al.  Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study , 2014, The Lancet. Infectious diseases.

[38]  G. Horsman,et al.  Whole-Genome Phylogenomic Heterogeneity of Neisseria gonorrhoeae Isolates with Decreased Cephalosporin Susceptibility Collected in Canada between 1989 and 2013 , 2014, Journal of Clinical Microbiology.

[39]  M. Unemo,et al.  Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance , 2015, BMC Infectious Diseases.

[40]  Magnus Unemo,et al.  Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge , 2015, BMC Infectious Diseases.

[41]  M. Unemo,et al.  Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland. , 2015, The Journal of antimicrobial chemotherapy.

[42]  Monica Lahra Australian Gonococcal Surveillance Programme annual report, 2013. , 2015, Communicable diseases intelligence quarterly report.

[43]  J. Bates,et al.  Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Australia. , 2014, The Journal of antimicrobial chemotherapy.

[44]  G. Horsman,et al.  Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada , 2016, Emerging infectious diseases.

[45]  AustrAliAn GonococcAl surveillAnce ProGrAmme AnnuAl rePort , 2022 .